| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.4M | — |
| SG&A Expense | $1.1M | +1008.3% |
| Operating Income | -$3.5M | -3503.8% |
| Interest Expense | $81K | +20.7% |
| Net Income | -$3.5M | -2480.5% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $372 | -67.2% |
| Current Assets | $3K | +156.6% |
| Total Assets | $767K | — |
| Current Liabilities | $3.8M | +394.8% |
| Long-term Debt | $184K | — |
| Total Liabilities | $4.8M | +327.5% |
| Stockholders' Equity | -$4.1M | -261.7% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$458K | -500.7% |
| Investing Cash Flow | -$6K | -350.6% |
| Financing Cash Flow | $463K | +508.9% |